Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bio-Path Holdings, Inc. - Common Stock
(NQ:
BPTH
)
0.2100
UNCHANGED
Last Price
Updated: 4:00 PM EST, Feb 18, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bio-Path Holdings, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Life Sciences Investor Forum: Now Available for Online Viewing
June 13, 2025
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Bio-Path Holdings to Present at Life Sciences Virtual Investor Forum
June 09, 2025
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
Life Sciences Investor Forum Agenda Announced for June 11th-12th
June 10, 2025
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q1 25
June 04, 2025
Dallas, Texas--(Newsfile Corp. - June 4, 2025) - Bio-Path Holdings, Inc. (OTCQB: BPTH): Stonegate Capital Partners Updates Coverage on Bio-Path...
Via
Newsfile
Topics
Intellectual Property
Bio-Path Holdings Provides Clinical and Operational Update
June 03, 2025
Highlights Promise of DNAbilize® Platform to Produce New Drug Candidates and Potential Licensing Opportunities
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
Bio-Path Holdings to Host Corporate Update Conference Call on May 29, 2025
May 22, 2025
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
Bio-Path Holdings Achieves Third Pre-Clinical Milestone Confirming Potential of BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients
May 01, 2025
Data suggest BP1001-A prevents fatty acid-induced insulin resistance in cells
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
Bio-Path Holdings Reports Full Year 2024 Financial Results
March 28, 2025
Reports Continued Progress Across Both Obesity and Oncology Franchises
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
Bio-Path Holdings Announces Pre-Clinical Results Signaling Increased Potential for BP1001-A as Treatment for Obesity in Type 2 Diabetes Patients
March 18, 2025
Recent Pre-Clinical Studies Showed BP1001-A Attenuated Fatty Acid-Induced Insulin Resistance and Restored Insulin Sensitivity in Muscle Progenitor and Skeletal Muscle Fiber Cell Models
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
↗
February 18, 2025
Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session.
Via
Chartmill
Which stocks are moving on Tuesday?
↗
February 18, 2025
Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via
Chartmill
Tuesday's session: gap up and gap down stocks
↗
February 18, 2025
In today's session, there are notable price gaps in the US markets on Tuesday. Take a closer look at the stocks that are gap up and gap down.
Via
Chartmill
US Stocks Mixed; NY State Business Activity Rises In February
↗
February 18, 2025
Via
Benzinga
Wondering what's happening in today's pre-market session?
↗
February 18, 2025
The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today.
Via
Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
February 18, 2025
Via
Benzinga
Bio-Path Holdings Expands Global Patent Portfolio
February 13, 2025
Builds on Global Intellectual Property Portfolio to Protect DNAbilize® Platform
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
Bio-Path Holdings Provides Key Clinical Updates
February 13, 2025
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
Wondering what's happening in today's after-hours session?
↗
February 12, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via
Chartmill
Bio-Path Holdings Provides Update from Phase 1/1b Clinical Trial of BP1002 for Treatment of Refractory/Relapsed Acute Myeloid Leukemia
February 12, 2025
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
Bio-Path Holdings Provides 2025 Clinical and Operational Update
January 10, 2025
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
December 19, 2024
Via
Benzinga
Nasdaq Jumps 100 Points, US Initial Jobless Claims Decline
↗
December 19, 2024
Via
Benzinga
Bio-Path Holdings Shares Were On The Rise: What's Going On?
↗
December 19, 2024
Bio-Path Holdings, Inc. (NASDAQ: BPTH) shares are surging Thursday following the company's announcement of encouraging preclinical results for BP1001-A, a potential treatment for obesity and Type 2...
Via
Benzinga
Gold Falls Sharply, Lamb Weston Shares Plunge
↗
December 19, 2024
Via
Benzinga
US Stocks Higher, Micron Reports Downbeat Sales
↗
December 19, 2024
Via
Benzinga
Bio-Path Holdings Announces Preclinical Testing of BP1001-A as Potential Treatment for Obesity in Type 2 Diabetes Patients Enhances Insulin Sensitivity
December 19, 2024
Preclinical Studies Confirmed BP1001-A Mechanism of Action and Therapeutic Potential in Obesity and Type 2 Diabetes
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q3 24
December 13, 2024
Dallas, Texas--(Newsfile Corp. - December 13, 2024) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): Stonegate Capital Partners Updates Coverage on Bio-Path...
Via
Newsfile
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
December 11, 2024
Via
Benzinga
Bio-Path Holdings Outlines Rationale for Development of BP1001-A as Potential Treatment for Obesity in Type 2 Diabetes Patients
December 11, 2024
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
Bio-Path Holdings Reports Third Quarter 2024 Financial Results
November 15, 2024
From
Bio-Path Holdings, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
